Browsing Harvard Medical School by Keyword "CD13"
Now showing items 1-1 of 1
-
Bone marrow-derived CD13+ cells sustain tumor progression: A potential non-malignant target for anticancer therapy
(Landes Bioscience, 2014)Non-malignant cells found within neoplastic lesions express alanyl (membrane) aminopeptidase (ANPEP, best known as CD13), and CD13-null mice exhibit limited tumor growth and angiogenesis. We have recently demonstrated that ...